Hinge Health (NYSE:HNGE) CEO Daniel Antonio Perez Sells 166,665 Shares of Stock

Hinge Health Inc. (NYSE:HNGE) CEO Daniel Antonio Perez sold 166,665 shares of the business’s stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $40.26, for a total value of $6,709,932.90. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Daniel Antonio Perez also recently made the following trade(s):

• On Monday, January 5th, Daniel Antonio Perez sold 166,665 shares of Hinge Health stock. The stock was sold at an average price of $46.38, for a total value of $7,729,922.70.
• On Monday, December 15th, Daniel Antonio Perez sold 166,670 shares of Hinge Health stock. The stock was sold at an average price of $48.53, for a total value of $8,088,495.10.

Hinge Health Trading Down 1.4%

Shares of NYSE:HNGE opened at $38.91 on Friday. Hinge Health Inc. has a twelve month low of $30.08 and a twelve month high of $62.18. The company’s 50 day moving average is $43.53 and its 200 day moving average is $48.75. The company has a market cap of $3.06 billion and a PE ratio of -2.97.

Hinge Health announced that its board has approved a stock repurchase plan on Wednesday, November 12th that allows the company to repurchase $250.00 million in outstanding shares. This repurchase authorization allows the company to purchase up to 7.2% of its shares through open market purchases. Shares repurchase plans are often a sign that the company’s board of directors believes its shares are undervalued.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the business. FNY Investment Advisers LLC acquired a new stake in Hinge Health in the 2nd quarter valued at $310,000. Strategic Blueprint LLC acquired a new stake in shares of Hinge Health in the second quarter valued at about $346,000. Emerald Advisers LLC purchased a new stake in shares of Hinge Health during the second quarter worth about $108,000. Mark Sheptoff Financial Planning LLC acquired a new position in shares of Hinge Health during the 2nd quarter worth about $114,000. Finally, Lisanti Capital Growth LLC purchased a new position in Hinge Health in the 2nd quarter valued at about $3,089,000.

Analysts Set New Price Targets

HNGE has been the subject of a number of research reports. Wall Street Zen downgraded shares of Hinge Health from a “buy” rating to a “hold” rating in a research report on Sunday, December 28th. Wells Fargo & Company began coverage on Hinge Health in a report on Thursday, January 8th. They issued an “overweight” rating and a $68.00 price objective for the company. Citizens Jmp restated a “market outperform” rating and issued a $65.00 target price on shares of Hinge Health in a research note on Wednesday. Needham & Company LLC reiterated a “buy” rating and set a $59.00 price target on shares of Hinge Health in a research report on Wednesday. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Hinge Health in a research report on Thursday, January 22nd. One analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Hinge Health has a consensus rating of “Moderate Buy” and a consensus target price of $57.71.

About Hinge Health

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.